Literature DB >> 8276801

Deamidation and isoaspartate formation during in vitro aging of recombinant tissue plasminogen activator.

M V Paranandi1, A W Guzzetta, W S Hancock, D W Aswad.   

Abstract

When incubated at pH 7.3, 37 degrees C, human recombinant tissue plasminogen activator accumulated 0.77 mol of isoaspartate per mol of plasminogen activator over a 14-day period. Isoaspartate was detected by enzymatic transfer of 3H-labeled methyl groups from S-adenosyl-L-methionine in a reaction catalyzed by protein L-isoaspartyl methyltransferase. Analysis of tryptic peptides derived from aged plasminogen activator revealed that the two major sites of isoaspartate accumulation resulted from deamidation of Asn58 in the sequence -FNGG- and Asn177 in the sequence -GNSD-. Significant levels of isoaspartate also accumulated via deamidation of Asn37 in the sequence -CNSG-. All three sites occur in sequences predicted from studies with synthetic peptide to be unstable. All three sites appear to be on the surface of the protein, and all three occur in regions of the protein predicted to have higher than average chain mobility. These findings add support to the idea that sequence and flexibility play major roles in determining susceptibility to deamidation and peptide bond isomerization at Asn and Asp sites under mild conditions. These studies also illustrate the utility of enzymatic methylation for characterizing sites of deamidation in a large protein that contains numerous disulfide bonds and several sites of glycosylation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8276801

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Selective cleavage of isoaspartyl peptide bonds by hydroxylamine after methyltransferase priming.

Authors:  Jeff X Zhu; Dana W Aswad
Journal:  Anal Biochem       Date:  2007-02-22       Impact factor: 3.365

2.  Isolation and identification of peptide degradation products of heat stressed pramlintide injection drug product.

Authors:  C Hekman; W DeMond; T Dixit; S Mauch; M Nuechterlein; A Stepanenko; J D Williams; M Ye
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

Review 3.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

4.  Elucidation of degradants in acidic peak of cation exchange chromatography in an IgG1 monoclonal antibody formed on long-term storage in a liquid formulation.

Authors:  Sejal Gandhi; Da Ren; Gang Xiao; Pavel Bondarenko; Christopher Sloey; Margaret Speed Ricci; Sampathkumar Krishnan
Journal:  Pharm Res       Date:  2011-08-16       Impact factor: 4.200

Review 5.  Deficiency in protein L-isoaspartyl methyltransferase results in a fatal progressive epilepsy.

Authors:  A Yamamoto; H Takagi; D Kitamura; H Tatsuoka; H Nakano; H Kawano; H Kuroyanagi; Y Yahagi; S Kobayashi; K Koizumi; T Sakai; K Saito; T Chiba; K Kawamura; K Suzuki; T Watanabe; H Mori; T Shirasawa
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

6.  Characterization of the isomerization products of aspartate residues at two different sites in a monoclonal antibody.

Authors:  Alavattam Sreedhara; Armando Cordoba; Qing Zhu; Jeanne Kwong; Jun Liu
Journal:  Pharm Res       Date:  2011-08-02       Impact factor: 4.200

7.  Integrated proteomic analysis of major isoaspartyl-containing proteins in the urine of wild type and protein L-isoaspartate O-methyltransferase-deficient mice.

Authors:  Shujia Dai; Wenqin Ni; Alexander N Patananan; Steven G Clarke; Barry L Karger; Zhaohui Sunny Zhou
Journal:  Anal Chem       Date:  2013-02-06       Impact factor: 6.986

8.  An 18O-labeling assisted LC/MS method for assignment of aspartyl/isoaspartyl products from Asn deamidation and Asp isomerization in proteins.

Authors:  Shunhai Wang; Igor A Kaltashov
Journal:  Anal Chem       Date:  2013-06-13       Impact factor: 6.986

9.  Mildly acidic conditions eliminate deamidation artifact during proteolysis: digestion with endoprotease Glu-C at pH 4.5.

Authors:  Shanshan Liu; Kevin Ryan Moulton; Jared Robert Auclair; Zhaohui Sunny Zhou
Journal:  Amino Acids       Date:  2016-01-09       Impact factor: 3.520

10.  Major degradation products of basic fibroblast growth factor: detection of succinimide and iso-aspartate in place of aspartate.

Authors:  Z Shahrokh; G Eberlein; D Buckley; M V Paranandi; D W Aswad; P Stratton; R Mischak; Y J Wang
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.